CAS 1613264-40-6

BAY 1316957

CAS: 1613264-40-6

BAY 1316957 is a drug that inhibits the enzyme glucuronidation. It is being investigated for the treatment of cancer and neurodegenerative diseases. BAY 1316957 has been shown to inhibit endometriotic lesions in the pelvic cavity, as well as expressed endometriosis. This drug has also been shown to have an anti-nociceptive effect in animal models of cancer. The pharmacokinetic properties of BAY 1316957 have been optimized by altering its receptor subtype.

Fórmula: C₂₇H₂₇N₃O₃

Pureza: Min. 95%

Peso molecular: 441.5 g/mol

Ref: 3D-NPC26440

BAY-1316957

CAS: 1613264-40-6

BAY-1316957 is a highly potent and selective EP4 receptor antagonist. With an IC50 of 15.3 nM. Good oral bioavailability[1].

Fórmula: C₂₇H₂₇N₃O₃

Cor e Forma: Solid

Peso molecular: 441.52

Ref: TM-T14500